Dilip Shanghvi of Sun Pharma, appears to have taken a first major wrong move. His family intends to acquire 23% stake in debt-laden Suzlon Energy with a preferential issue of fresh equity of for Rs 1,800 crore, leaving the Tulsi Tanti family with a 24% stake in the wind turbine maker. Suzlon has been struggling from the last one decade to stay afloat.
No comments:
Post a Comment